Company intelligence / Profile preview

Celerion

Lincoln, Nebraska, United Statescelerion.com ↗

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

As one of the world’s leading early phase contract research organizations (CROs), Celerion provides comprehensive services in early clinical development (Phase 0–IIa), including first-in-human studies, proof-of-concept trials, bioanalytical services, PK/PD modeling, and regulatory support. The company does not develop its own drugs but enables faster go/no-go decisions for client pipelines by delivering high-quality data rapidly. No direct clinical results are reported since it does not have its own pipeline.

Therapeutic areas: Other
Modalities: small moleculesbiologics
Industry: Contract Research Organization

Partnerships

Collaborates with global pharmaceutical and biotechnology companies

Beyond the preview

Go deeper on Celerion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celerion.

Explore the full profile